Prognostic Relevance of Clinical and Biological Risk Factors in Childhood Medulloblastoma: Results of Patients Treated in the Prospective Multicenter Trial HIT'91

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Clinical Cancer Research

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-06-1779PMID 17473196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Attention and memory functioning among pediatric patients with medulloblastoma.

  2006cited by this paper
• Quantitative mRNA expression analysis of neurotrophin‐receptor TrkC and oncogene c‐MYC from formalin‐fixed, paraffin‐embedded primitive neuroectodermal tumor samples

  2006cited by this paper
• Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.

  2006cited by this paper
• Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.

  2005cited by this paper
• Medulloblastoma: signalling a change in treatment.

  2004cited by this paper
• Combined Histopathological and Molecular Cytogenetic Stratification of Medulloblastoma Patients

  2004cited by this paper
• Histopathological and Molecular Prognostic Markers in Medulloblastoma: c‐myc, N‐myc, TrkC, and Anaplasia

  2004cited by this paper
• c-Myc promoter activation in medulloblastoma.

  2003cited by this paper
• Molecular Biology of Medulloblastoma Therapy

  2003cited by this paper
• Medulloblastoma: Present Concepts of Stratification into Risk Groups

  2003cited by this paper
• Anaplasia and Grading in Medulloblastomas

  2003cited by this paper
• N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation.

  2002cited by this paper
• MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group.

  2002cited by this paper
• The WHO Classification of Tumors of the Nervous System

  2002cited by this paper
• Comparative Genomic Hybridization Detects An Increased Number of Chromosomal Alterations in Large Cell/Anaplastic Medulloblastomas

  2002cited by this paper
• MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.

  2001cited by this paper
• Clinical and molecular stratification of disease risk in medulloblastoma

  2001cited by this paper
• Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

  2000cited by this paper
• TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors.

  2000cited by this paper
• The Myc/Max/Mad network and the transcriptional control of cell behavior.

  2000cited by this paper
• C‐MYC expression in medulloblastoma and its prognostic value

  2000cited by this paper
• Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas.

  1999cited by this paper
• Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

  1999cited by this paper
• Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

  1999cited by this paper
• MYC oncogenes and human neoplastic disease

  1999cited by this paper
• A Rapid and Sensitive Protocol for Competitive Reverse Transcriptase (cRT) PCR Analysis of Cellular Genes

  1998cited by this paper
• Modern treatment strategies in medulloblastoma

  1998cited by this paper
• Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome.

  1998cited by this paper
• Expression of the c‐Myc Protein in Childhood Medulloblastoma

  1998cited by this paper
• 4. Modelling Survival Data in Medical Research

  1995cited by this paper
• Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma.

  1994cited by this paper
• An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas.

  1969cited by this paper

• Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtype

  2024influential citation
• B7-H6 enhances F-actin rearrangement by targeting c-MYC activation to promote medulloblastoma migration and invasion

  2023cites this paper
• A Novel Low Recurrence Surgical Approach for Medulloblastoma Excision: A Study of 58 cases.

  2020cites this paper
• Neurotrophin Signaling in Medulloblastoma

  2020cites this paper
• CLINICAL, DEMOGRAPHIC, ANATOMOPATHOLOGICAL, AND MOLECULAR FINDINGS IN PATIENTS WITH MEDULLOBLASTOMA TREATED IN A SINGLE HEALTH FACILITY

  2020cites this paper
• Stage at diagnosis for childhood solid cancers in Australia: A population-based study.

  2019cites this paper
• Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma

  2018cites this paper
• Estudio molecular en meduloblastomas pediátricos: determinación y validación de marcadores genéticos para la estratificación del tratamiento adaptado a factores de riesgo clínico y biológico

  2017cites this paper
• Ganglioglioma Arising From Desmoplastic Medulloblastoma: A Case Report and Review of Literature

  2017cites this paper
• Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response

  2017cites this paper
• Modern management of medulloblastoma: Molecular classification, outcomes, and the role of surgery

  2016cites this paper
• Biomarker-driven stratiication of disease-risk in non-metastatic medulloblastoma : Results from the multi-center HIT-SIOP-PNET 4 clinical trial

  2016cites this paper
• [Evolution of the management of pediatric and adult medulloblastoma].

  2015influential citation
• MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown

  2015cites this paper
• Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial

  2015cites this paper
• Évolution de la prise en charge des médulloblastomes de l’enfant et de l’adulte

  2015cites this paper
• Medulloblastoma with soft-tissue and skeletal metastases in an adult: A case report.

  2015cites this paper
• Chemotherapy for children with medulloblastoma.

  2015cites this paper
• Genetic-epigenetic interactions in medulloblastoma development

  2014cites this paper
• Firmas Génicas de respuesta al tratamiento neoadyuvante en el cáncer de recto

  2014cites this paper
• MRI Characteristics of Ependymoblastoma: Results from 22 Centrally Reviewed Cases

  2014cites this paper
• Medulloblastomas in adults: lessons from pediatrics

  2014cites this paper
• Immunohistochemical expression of Ki67, EGFR and TRKC and their correlation with prognostic factors in medulloblastoma

  2014cites this paper
• Análise das frequências dos subgrupos moleculares dos meduloblastomas e associações com possíveis fatores prognósticos

  2014cites this paper
• Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.

  2013cites this paper
• G-Quadruplexes as Potential Therapeutic Targets for Embryonal Tumors

  2013cites this paper
• Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group

  2013cites this paper
• DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies

  2013cites this paper
• MicroRNAs in Medulloblastoma

  2013cites this paper
• Effetti dell'inibizione di Tanchirasi in linee cellulari di Medulloblastoma umano

  2013cites this paper
• Medulloblastoma.

  2013cites this paper
• Biological and clinical heterogeneity of MYCN-amplified medulloblastoma

  2012cites this paper
• Genetic Alterations in MicroRNAs in Medulloblastomas

  2012influential citation
• Molecular subclassification of medulloblastoma and its utility for disease prognostication

  2012cites this paper
• Isochromosome 17q, MYC amplification and large cell/anaplastic phenotype in a case of medullomyoblastoma with extracranial metastases

  2012cites this paper
• The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.

  2012cites this paper
• Biological and clinical heterogeneity of MYCN-amplified

  2012cites this paper
• A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma.

  2012cites this paper
• Neuroimaging of pediatric posterior fossa tumors including review of the literature

  2012cites this paper
• Medulloblastomas in adults: prognostic factors and lessons from paediatrics.

  2011cites this paper
• The tumor biology and molecular characteristics of medulloblastoma identifying prognostic factors associated with survival outcomes and prognosis.

  2011cites this paper
• Loss of 10q26.1-q26.3 in association with 7q34-q36.3 gain or 17q24.3-q25.3 gain predict poor outcome in pediatric medulloblastoma.

  2011cites this paper
• The phosphoinositide 3-kinase signaling pathway as a therapeutic target in grade IV brain tumors.

  2011cites this paper
• Expression of O6-methylguanine-DNA methyltransferase in childhood medulloblastoma

  2011cites this paper
• Expression of O 6 -methylguanine-DNA methyltransferase in childhood medulloblastoma Denis FaoroAndreO. von BuerenTarek ShalabyDavide Sciuscio • Marie-Louise HurlimannLucia ArnoldNicolas U. GerberJohannes Haybaeck • Michel MittelbronnStefan RutkowskiMonika HegiMichael A. Grotzer

  2011cites this paper
• Identification of c-myc-dependent proteins in the medulloblastoma cell line D425Med

  2011cites this paper
• Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma

  2011cites this paper
• Childhood medulloblastoma.

  2011cites this paper
• p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease

  2011cites this paper
• MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma

  2011cites this paper
• TH1 predominance is associated with improved survival in pediatric medulloblastoma patients

  2011cites this paper
• Molecular Diagnostics in Embryonal Brain Tumors

  2011cites this paper
• Supratentorial Primitive Neuroectodermal Tumors of the Central Nervous System in Adults: Molecular and Histopathologic Analysis of 12 Cases

  2011cites this paper
• c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients

  2011influential citation
• Histone deacetylase inhibitors prime medulloblastoma cells for chemotherapy-induced apoptosis by enhancing p53-dependent Bax activation

  2011cites this paper
• TP53, β‐Catenin and c‐myc/N‐myc status in embryonal tumours with ependymoblastic rosettes

  2011cites this paper
• Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features.

  2011cites this paper
• High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma.

  2011cites this paper
• Cancer esearch or and Stem Cell Biology ncing of Thrombospondin-1 Is Critical for Myc-Induced R astatic Phenotypes in Medulloblastoma

  2010cites this paper
• Meduloblastomas en adultos, estudio clínico patológico

  2010cites this paper
• Recurrence in medulloblastoma – Influence of clinical, histological and immunohistochemical factors

  2010cites this paper
• Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma.

  2010cites this paper
• Polycomb genes expression as a predictor of poor clinical outcome in children with medulloblastoma

  2010cites this paper
• Treatment of posterior fossa tumors in children

  2010cites this paper
• 4. Embryonal Tumors

  2010cites this paper
• ncing of Thrombospondin-1 Is Critical for Myc-Induced

  2010cites this paper
• A Case of Relapsed Medulloblastoma Treated with Intensity-Modulated Radiotherapy and Temozolomide

  2010cites this paper
• A case of relapsed medulloblastoma treated with intensity-modulated radiotherapy and temozolomide.

  2010cites this paper
• Large cell/anaplastic medulloblastoma: Outcome according to myc status, histopathological, and clinical risk factors

  2010influential citation
• Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease

  2010cites this paper
• Pediatric brain tumors: Current treatment strategies and future therapeutic approaches

  2009cites this paper
• Medulloblastoma

  2009cites this paper
• [Childhood and adult medulloblastoma: what difference?].

  2009cites this paper
• The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials

  2009cites this paper
• Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.

  2009cites this paper
• Medulloblastoma Variants: Age-Dependent Occurrence and Relation to Gorlin Syndrome—A New Clinical Perspective

  2009cites this paper
• Loss of fine motor function correlates with ataxia and decline of cognition in cerebellar tumor survivors

  2009cites this paper
• Medulloblastomas: a correlative study of MIB-1 proliferation index along with expression of c-Myc, ERBB2, and anti-apoptotic proteins along with histological typing and clinical outcome

  2009cites this paper
• Intraventricular brain tumors in children

  2009cites this paper
• Classic and desmoplastic medulloblastoma: Complete case reports and characterizations of two new cell lines

  2009cites this paper
• Beta‐catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics

  2009cites this paper
• Targeting Myc in pediatric malignancies of the central and peripheral nervous system.

  2009cites this paper
• Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma.

  2009cites this paper
• Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91.

  2009cites this paper
• Neurotrophin 3/TrkC‐regulated proteins in the human medulloblastoma cell line DAOY

  2009cites this paper
• KAPITEL 13 – Neuroonkologie

  2009cites this paper
• Molecular Signatures of Localized Clear Cell Renal Cell Carcinoma to Predict Disease-Free Survival after Nephrectomy

  2009cites this paper
• Meduloblastoma: aspectos diferenciales entre el tumor infantil y del adulto

  2009cites this paper
• Le médulloblastome de l’enfant et de l’adulte : quelle différence ?

  2009cites this paper
• Cribriform Neuroepithelial Tumor (CRINET): A Nonrhabdoid Ventricular Tumor With INI1 Loss and Relatively Favorable Prognosis

  2009cites this paper
• RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells

  2009cites this paper
• Molecular Pathways Trk Receptor Expression and Inhibition in Neuroblastomas

  2009cites this paper
• Histone deacetylase inhibitors cooperate with IFN-γ to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8

  2009cites this paper
• Trk Receptor Expression and Inhibition in Neuroblastomas

  2009cites this paper
• Accumulation of genomic aberrations during clinical progression of medulloblastoma

  2008cites this paper
• MolecularRiskStratificationofMedulloblastomaPatientsBasedon ImmunohistochemicalAnalysisofMYC , LDHB , andCCNB 1 Expression

  2008cites this paper
• Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.

  2008cites this paper
• Pathological and molecular heterogeneity of medulloblastoma

  2008cites this paper
• Medulloblastoma, Primitive Neuroectodermal Tumors, and Pineal Tumors

  2008cites this paper
• Biomarkers and cancer stem cells in primary brain tumors. Foreword.

  2008cites this paper